The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Presky, D. H.
Right arrow Articles by Shevach, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Presky, D. H.
Right arrow Articles by Shevach, E. M.

The Journal of Immunology, Vol 144, Issue 3 860-868, Copyright © 1990 by American Association of Immunologists


ARTICLES

Role of phosphatidylinositol-anchored proteins in T cell activation

DH Presky, MG Low and EM Shevach
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

A novel class of cell surface proteins are attached to the plasma membrane via a phosphatidylinositol (PI)-glycan anchoring structure, and these proteins can be selectively removed from the cell surface by the enzyme PI-specific phospholipase C (PI-PLC). Enzyme treatment led to a prolonged reduction in cell surface expression of several PI- anchored proteins. Activation of T cells led to a marked decrease in the ability of PI-PLC to remove PI-anchored surface proteins from the activated T cells. This decrease in PI-PLC sensitivity may reflect an alteration in the PI-glycan anchoring structures, or in a general membrane property, which renders the PI-anchored proteins inaccessible to the enzyme. When murine T lymphocytes were treated with PI-PLC and then stimulated with either Con A, the calcium ionophore A23187 and PMA, or an anti-CD3 mAb, the response to Con A stimulation was inhibited by 90%, whereas the responses to ionophore and PMA or anti- CD3 were not affected. Removal of PI-anchored proteins inhibited an early event in the activation process in response to Con A because both IL-2 production and IL-2R expression were inhibited by the PI-PLC treatment. Inhibition of the Con A response was secondary to removal of a PI-linked protein from the responder T cell population because PI-PLC treatment of T-depleted spleen cells did not alter their ability to act as a source of accessory cells. It is unlikely that removal of the known PI-linked proteins on murine T cells, Thy-1 and Ly-6, can fully account for the inhibition of Con A response because the cell line M2B3, that lacks these surface proteins, responded normally to Con A stimulation. These studies demonstrate that one or more PI-anchored T cell proteins play an important role in an early step of Con A activation, perhaps involving T cell-accessory cell interactions. In contrast, the ability to stimulate T cells by direct cross-linking of TCR/CD3 complex is not dependent on the presence of these PI-anchored proteins.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani
Physiology of the Prion Protein
Physiol Rev, April 1, 2008; 88(2): 673 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Terrazzano, M. Sica, C. Becchimanzi, S. Costantini, B. Rotoli, S. Zappacosta, F. Alfinito, and G. Ruggiero
T cells from paroxysmal nocturnal haemoglobinuria (PNH) patients show an altered CD40-dependent pathway
J. Leukoc. Biol., July 1, 2005; 78(1): 27 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Khalili-Shirazi, S. Quaratino, M. Londei, L. Summers, M. Tayebi, A. R. Clarke, S. H. Hawke, G. S. Jackson, and J. Collinge
Protein Conformation Significantly Influences Immune Responses to Prion Protein
J. Immunol., March 15, 2005; 174(6): 3256 - 3263.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. M. Haeryfar and D. W. Hoskin
Thy-1: More than a Mouse Pan-T Cell Marker
J. Immunol., September 15, 2004; 173(6): 3581 - 3588.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Staffler, A. Szekeres, G. J. Schutz, M. D. Saemann, E. Prager, M. Zeyda, K. Drbal, G. J. Zlabinger, T. M. Stulnig, and H. Stockinger
Selective Inhibition of T Cell Activation Via CD147 Through Novel Modulation of Lipid Rafts
J. Immunol., August 15, 2003; 171(4): 1707 - 1714.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. M. Cerasoli, G. Kelsoe, and M. Sarzotti
CD4+Thy1- thymocytes with a Th-type 2 cytokine response
Int. Immunol., January 1, 2001; 13(1): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Y. S. Chuang, M. Sassaroli, and J. C. Unkeless
Convergence of Fc{gamma} Receptor IIA and Fc{gamma} Receptor IIIB Signaling Pathways in Human Neutrophils
J. Immunol., January 1, 2000; 164(1): 350 - 360.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. J. Richards, G. J. Morgan, and P. Hillmen
Analysis of T Cells in Paroxysmal Nocturnal Hemoglobinuria Provides Direct Evidence That Thymic T-Cell Production Declines With Age
Blood, October 15, 1999; 94(8): 2790 - 2799.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.